Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Salinas › NPI 1063616613
Hospital

Hsp40248f

Hsp40248f was paid $47.26M by Medicaid between Jan 2018 and Nov 2024, across 305 billing codes. Its largest line is 99281, Emergency department visit for the evaluation and management, self-limited or minor — 26% of everything it billed.

33Billing provider infoHSP40248F
SALINAS, CA 93906
33aNPI1063616613assigned 06/14/2007
33bProvider typeGeneral Acute Care Hospital
28Total paid$47.26M
24GClaims1,422,670
24DCodes billed305
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#66 of 410
Median peer was paid$6.90M
This provider vs. median6.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018204,831$5.95M
2019199,725$5.86M
2020141,944$4.28M
2021193,017$6.72M
2022219,206$8.11M
2023235,783$8.22M
2024incomplete228,164$8.11M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99281 Emergency department visit for the evaluation and management, self-limited or minor 26% 195,260 181,790 $12.30M
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 7.0% 92,058 82,140 $3.29M
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 5.7% 7,393 7,139 $2.71M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 4.8% 21,576 8,898 $2.29M
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 3.9% 13,133 12,945 $1.85M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2.0% 13,735 13,608 $964K
70450 Computed tomography, head or brain; without contrast material 1.9% 4,513 4,433 $891K
97530 Therapeutic activities, direct patient contact, each 15 minutes 1.8% 18,652 8,063 $846K
80053 Comprehensive metabolic panel 1.7% 77,837 75,070 $809K
59025 Fetal non-stress test 1.6% 21,174 17,416 $773K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.5% 22,376 21,502 $719K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.5% 4,435 4,419 $709K
293 more codes
Z7502 1.4% 18,463 $678K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1.4% 8,442 $673K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.4% 2,925 $668K
T1999 Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" 1.4% 178,492 $660K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.3% 83,278 $637K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.3% 10,808 $626K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 1.3% 9,114 $622K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 1.0% 9,791 $485K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 6,699 $450K
71046 Radiologic examination, chest; 2 views <1% 17,605 $403K
72125 Computed tomography, cervical spine; without contrast material <1% 1,422 $402K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 3,583 $388K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 5,073 $385K
77067 Screening mammography, bilateral, including computer-aided detection <1% 3,102 $385K
84443 Thyroid stimulating hormone (TSH) <1% 22,117 $379K
97799 <1% 13,227 $373K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 3,180 $352K
76830 Ultrasound, transvaginal <1% 4,251 $322K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 621 $307K
76801 <1% 4,234 $276K
80061 Lipid panel <1% 19,821 $271K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 8,778 $271K
93303 Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study <1% 1,316 $254K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 6,302 $224K
99243 <1% 3,348 $224K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 6,252 $222K
Z7610 <1% 13,810 $217K
83036 Hemoglobin; glycosylated (A1C) <1% 21,430 $212K
86480 <1% 4,855 $205K
93325 <1% 1,340 $198K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 2,847 $194K
S0302 Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) <1% 1,721 $193K
81001 <1% 56,377 $180K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 7,923 $177K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 5,357 $170K
96375 Therapeutic injection; each additional sequential IV push <1% 3,730 $167K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 773 $157K
87536 <1% 1,750 $156K
87088 <1% 19,270 $154K
76770 <1% 1,675 $153K
71275 Computed tomographic angiography, chest, with contrast material <1% 623 $148K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 2,265 $144K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 3,203 $142K
73610 <1% 4,349 $133K
87086 Culture, bacterial; quantitative colony count, urine <1% 15,571 $130K
73630 <1% 4,663 $130K
93971 <1% 993 $127K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 3,279 $109K
81025 <1% 15,831 $106K
73110 <1% 3,548 $106K
83690 <1% 14,650 $100K
73562 <1% 3,601 $96K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 1,116 $95K
93320 <1% 1,051 $95K
77063 Screening digital breast tomosynthesis, bilateral <1% 3,039 $95K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 4,404 $89K
86803 <1% 5,443 $79K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 6,159 $79K
76642 <1% 1,123 $78K
73030 <1% 2,549 $76K
84484 <1% 6,284 $75K
73130 <1% 2,471 $74K
73080 <1% 2,127 $69K
71250 <1% 332 $67K
92523 <1% 520 $66K
70551 Magnetic resonance imaging, brain; without contrast material <1% 128 $66K
72110 <1% 1,174 $65K
84439 <1% 6,930 $64K
80048 Basic metabolic panel (calcium, ionized) <1% 7,691 $64K
71045 Radiologic examination, chest; single view <1% 5,252 $63K
97165 <1% 928 $61K
87430 <1% 4,077 $59K
Z7500 <1% 1,741 $59K
76870 <1% 794 $59K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 487 $59K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 42 $54K
84702 <1% 3,628 $53K
74018 <1% 2,424 $52K
93017 <1% 1,228 $52K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 6,402 $51K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 461 $51K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 86 $49K
83880 <1% 1,674 $48K
87186 <1% 4,882 $47K
90378 <1% 17 $47K
80081 <1% 648 $45K
99367 <1% 752 $44K
0450 Emergency room services <1% 1,366 $43K
73590 <1% 1,670 $41K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 670 $39K
83550 <1% 4,344 $39K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 463 $39K
86361 <1% 1,498 $35K
L8699 Prosthetic implant, not otherwise specified <1% 13 $34K
J2785 Injection, regadenoson, 0.1 mg <1% 276 $34K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 742 $34K
87040 <1% 2,180 $33K
93225 <1% 923 $32K
73502 <1% 1,003 $31K
83605 <1% 2,579 $30K
82570 <1% 5,797 $30K
83540 <1% 4,513 $30K
T1024 Evaluation and treatment by an integrated, specialty team contracted to provide coordinated care to multiple or severely handicapped children, per encounter <1% 907 $30K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 582 $29K
73140 <1% 1,490 $29K
82728 <1% 2,096 $29K
73560 <1% 1,438 $29K
86756 <1% 1,789 $28K
82962 <1% 7,671 $28K
76536 <1% 430 $28K
83970 <1% 1,248 $28K
47562 <1% 93 $28K
85610 <1% 9,507 $27K
86850 <1% 2,851 $26K
88304 <1% 938 $25K
87205 <1% 5,224 $24K
72100 <1% 686 $24K
93970 <1% 119 $24K
80069 <1% 2,686 $24K
82043 <1% 3,836 $23K
86703 <1% 1,356 $23K
87400 <1% 3,873 $22K
73090 <1% 852 $21K
82746 <1% 1,351 $20K
87340 <1% 1,930 $20K
86140 <1% 3,693 $19K
85027 <1% 2,909 $19K
86706 <1% 1,744 $18K
87081 <1% 2,672 $18K
J3490 Unclassified drugs <1% 657 $18K
83655 <1% 3,058 $18K
73221 <1% 44 $18K
86787 <1% 1,285 $17K
73000 <1% 638 $17K
A9585 Injection, gadobutrol, 0.1 ml <1% 568 $17K
J0690 Injection, cefazolin sodium, 500 mg <1% 3,066 $16K
85730 <1% 2,766 $16K
J7030 Infusion, normal saline solution , 1000 cc <1% 2,511 $16K
86704 <1% 1,254 $15K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 407 $14K
86592 <1% 3,319 $14K
87899 <1% 485 $14K
86709 <1% 1,213 $14K
72070 <1% 385 $14K
73552 <1% 551 $14K
84238 <1% 325 $13K
93226 <1% 225 $13K
83735 <1% 1,852 $12K
99368 <1% 748 $12K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 43 $12K
76000 <1% 430 $11K
86900 <1% 3,836 $11K
86901 <1% 3,779 $11K
82274 <1% 756 $11K
80076 <1% 1,325 $11K
85007 <1% 2,835 $11K
84425 <1% 464 $10K
84703 <1% 1,288 $9K
84235 <1% 131 $9K
85652 <1% 3,324 $9K
77066 Tomosynthesis, mammo <1% 68 $9K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 209 $8K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 2,118 $8K
86038 <1% 936 $8K
73564 <1% 214 $7K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 219 $7K
82607 <1% 472 $7K
84156 <1% 2,155 $7K
82247 <1% 1,226 $7K
90686 <1% 370 $6K
80055 <1% 119 $6K
72081 <1% 189 $6K
82525 <1% 440 $6K
85379 <1% 596 $6K
86762 <1% 232 $6K
84630 <1% 537 $6K
70498 <1% 25 $6K
86780 <1% 458 $5K
Q0111 Wet mounts, including preparations of vaginal, cervical or skin specimens <1% 1,429 $5K
G0109 Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes <1% 261 $5K
84481 <1% 285 $5K
87077 <1% 692 $5K
85018 <1% 2,020 $5K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 1,304 $5K
87210 <1% 427 $5K
87045 <1% 474 $5K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 919 $5K
82550 <1% 695 $4K
84590 <1% 362 $4K
94060 <1% 135 $4K
75574 <1% 16 $4K
84460 <1% 755 $4K
81002 <1% 1,216 $4K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 79 $4K
99199 Unlisted special service, procedure or report <1% 76 $4K
G0442 Annual alcohol misuse screening, 5 to 15 minutes <1% 173 $4K
82248 <1% 712 $4K
82784 <1% 255 $3K
83525 <1% 300 $3K
77080 <1% 78 $3K
83516 <1% 233 $3K
70486 <1% 12 $3K
77065 Tomosynthesis, mammo <1% 31 $3K
72190 <1% 81 $3K
86039 <1% 315 $3K
84100 <1% 558 $3K
84403 <1% 116 $3K
84550 <1% 572 $3K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 93 $2K
J1439 Injection, ferric carboxymaltose, 1 mg <1% 367 $2K
92526 <1% 51 $2K
84450 <1% 417 $2K
92587 <1% 28 $2K
72052 <1% 37 $2K
J0780 Injection, prochlorperazine, up to 10 mg <1% 184 $2K
90656 <1% 84 $2K
87522 Neg quan hep c or qual rna <1% 42 $2K
94375 <1% 73 $2K
76813 <1% 27 $2K
82950 <1% 400 $2K
J2270 Injection, morphine sulfate, up to 10 mg <1% 263 $2K
73100 <1% 83 $2K
86308 <1% 316 $2K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 429 $2K
76882 <1% 136 $2K
92567 <1% 37 $1K
82565 <1% 275 $1K
88262 <1% 12 $1K
71020 <1% 42 $1K
73060 <1% 57 $1K
73070 <1% 51 $1K
86341 <1% 55 $1K
83014 <1% 163 $1K
72170 <1% 48 $1K
73660 <1% 66 $1K
84153 <1% 58 $1K
86376 <1% 87 $1K
82951 <1% 85 $1K
87046 <1% 199 $994.79
94726 <1% 26 $974.37
82652 <1% 48 $940.00
88720 <1% 217 $934.88
86593 <1% 213 $932.80
J7050 Infusion, normal saline solution, 250 cc <1% 204 $923.95
94729 <1% 25 $879.90
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 285 $862.03
J2372 Injection, phenylephrine hydrochloride (biorphen), 20 micrograms <1% 177 $772.90
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 86 $716.88
82610 <1% 47 $694.60
82105 <1% 40 $657.54
86360 <1% 14 $633.63
85045 <1% 138 $586.22
84402 <1% 25 $562.50
92582 <1% 13 $543.71
83001 <1% 50 $472.56
83520 <1% 27 $458.12
84146 <1% 24 $454.09
J1030 Injection, methylprednisolone acetate, 40 mg <1% 32 $408.29
84520 <1% 112 $396.84
94664 <1% 46 $379.50
73600 <1% 16 $372.45
86430 <1% 59 $370.10
87070 <1% 41 $345.83
82803 <1% 14 $345.67
97535 Self-care/home management training, each 15 minutes <1% 14 $335.92
J2704 Injection, propofol, 10 mg <1% 112 $334.20
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 42 $314.61
73620 <1% 16 $293.67
82310 <1% 54 $293.65
93270 <1% 12 $271.36
82270 <1% 58 $263.72
70360 <1% 12 $250.20
87147 <1% 44 $246.62
86255 <1% 14 $237.94
82977 <1% 29 $229.74
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 3,270 $198.40
92551 <1% 12 $196.68
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 30 $191.56
87209 <1% 43 $185.41
87177 <1% 43 $184.97
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 42 $183.12
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 13 $143.60
97162 <1% 25 $140.16
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 29 $126.28
83002 <1% 12 $117.78
0270 <1% 49 $105.86
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 13 $62.82
J0461 Injection, atropine sulfate, 0.01 mg <1% 13 $54.17
36415 Collection of venous blood by venipuncture <1% 3,616 $45.67
G0008 Administration of influenza virus vaccine 0% 81 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 30 $0.00
90662 0% 15 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 59 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLEON, DANIEL (C.F.O.)